BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20302655)

  • 1. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.
    Lee CH; Hung HW; Hung PH; Shieh YS
    Mol Cancer; 2010 Mar; 9():64. PubMed ID: 20302655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-catenin signaling and regulation of cyclin D1 promoter in NRK-49F cells transformed by down-regulation of the tumor suppressor lysyl oxidase.
    Giampuzzi M; Oleggini R; Albanese C; Pestell R; Di Donato A
    Biochim Biophys Acta; 2005 Sep; 1745(3):370-81. PubMed ID: 15946752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aurora kinase A regulates GSK-3beta in gastric cancer cells.
    Dar AA; Belkhiri A; El-Rifai W
    Oncogene; 2009 Feb; 28(6):866-75. PubMed ID: 19060929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers.
    Liu Y; Borchert GL; Surazynski A; Phang JM
    Oncogene; 2008 Dec; 27(53):6729-37. PubMed ID: 18794809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells.
    Guturi KK; Mandal T; Chatterjee A; Sarkar M; Bhattacharya S; Chatterjee U; Ghosh MK
    J Biol Chem; 2012 May; 287(22):18287-96. PubMed ID: 22493441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
    Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
    Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system.
    Latasa MU; Salis F; Urtasun R; Garcia-Irigoyen O; Elizalde M; Uriarte I; Santamaria M; Feo F; Pascale RM; Prieto J; Berasain C; Avila MA
    PLoS One; 2012; 7(12):e52711. PubMed ID: 23285165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
    Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
    Yang W; Xia Y; Ji H; Zheng Y; Liang J; Huang W; Gao X; Aldape K; Lu Z
    Nature; 2011 Dec; 480(7375):118-22. PubMed ID: 22056988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
    Takahashi-Yanaga F; Sasaguri T
    Cell Signal; 2008 Apr; 20(4):581-9. PubMed ID: 18023328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells.
    Cho IR; Koh SS; Min HJ; Kim SJ; Lee Y; Park EH; Ratakorn S; Jhun BH; Oh S; Johnston RN; Chung YH
    Exp Mol Med; 2011 Feb; 43(2):82-90. PubMed ID: 21196815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.
    Bjorklund CC; Ma W; Wang ZQ; Davis RE; Kuhn DJ; Kornblau SM; Wang M; Shah JJ; Orlowski RZ
    J Biol Chem; 2011 Apr; 286(13):11009-20. PubMed ID: 21189262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.